Research and Clinical Strategies for Treatment Resistant Depression: Buyer Beware!

Amsterdam, J.D. , & Hornig-Rohan, M. (1996). Treatment algorithms in treatment resistant depression. Tbe Psychiatric Clinics of North America, 19,371-385.

Depression Guideline Panel . (1993, April). Depression in primary care. Vol. 1. Detection and diagnosis. Clinical practice guidelines. No. 5. Rockville, MD: US Dept. of Health & Human Services, Agency for Health Care Policy and Research Publication No. 93-0550.

Depression Guideline Panel . (1993, April). Depression in primary care: Vol. 2. Treatment of major depression. Clinicalpractice guidelines. No. 5. Rockville, MD: US Dept. of Health & Human Services, Agency for Health Care Policy and Research Publication No. 93-0551.

Depression Guideline Panel . (1993, April). Depression in primary care: Detection, diagnosis & treatment. Quick reference guide for clinicians. No. 5. Rockville, MD: US Dept. of Health & Human Services, Agency for Health Care Policy and Research Publication No. 93-0552.

Depression Guideline Panel . (1993, April). Depression is a treatable illness. A patient's guide. No. 5. Rockville, MD: US Dept. of Health & Human Services, Agency for Health Care Policy and Research Publication No. 93-0553.

Fava, M. , Rosenbaum, J.F. , Cohen, L. , Reiter, S. , McCarthy, M. , Steingard, R. , & Clancy, K. (1992). High dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine. Journal of Affective Disorders, 25, 229-234.

Friedman, R.A. , & Kocsis, J.H. (1996). Pharmacotherapy for chronic depression. The Psychiatric Clinics of North America, 19, 121-132.

Hornig-Rohan, M. , Wolkowitz, O.M. , & Amsterdam, J.D. (1996). Novel strategies for treatment resistant depression. The Psychiatric Clinics of North America, 19, 387-405.

Howland, R.H. (1993). Thyroid dysfunction in refractory depression: Implications for pathophysiology and treatment. Journal of Clinical Psychiatry, 54, 47-54.

McGrath, P.J. , Stewart, J.W. , Nunes, E.V. , Ocepek-Welikson, K. , Rabkin, J.G. , Quitkin, F.M. , & Klein, D.F. (1993). A double blind crossover trial of imipramine and phenelzine for outpatients with treatment refractory depression. American Journal of Psychiatry, 150, 118-123.

Nelsen, M.R. , & Dunner, D.L. (1993). Treatment resistance in unipolar depression and other disorders: Diagnostic concerns and treatment possibilities. Psychiatric Clinics of North America, 16, 541-566.

Nierenberg, A.A. , Feighner, J.P. , Rudolph, R. , Cole, J.O. , & Sullivan, J. (1994). Venlafaxine for treatment resistant unipolar depression. Journal of Clinical Psychopharmacology, 14, 419-423.

Nierenberg, A.A. , McLean, N.E. , Alpert, J.E. , Worthington, J.J. , Rosenbaum, J.F. , & Fava, M. (1995). Early nonresponse to fluoxetine as a predictor of poor 8 week outcome. American Journal of Psychiatry, 152,1500-1503.

Stewart, J.W. , McGrath, P.J. , Quitkin, F.M. , Rabkin, J.G. , Harrison, W. , Wager, S. , Nunes, E. , Ocepek-Welikson, K. , & Tricamo, E. (1993). Chronic depression: Response to placebo, imipramine and phenelzine. Journal of Clinical Psychopharmacology, 13, 391-396.

Thase, M.E. , & Rush, A.J. (1995). Treatment resistant depression. In Bloom, F.E. , & Kupfer, DJ. (Eds.), Psychopharmacology: The fourth generation ofprogress (pp. 1081-1097). New York: Raven Press, Ltd.